Literature DB >> 31953566

Liquisolid Pellets and Liqui-Pellets Are Not Different.

Bianca Ramos Pezzini1, André O'Reilly Beringhs2, Humberto Gomes Ferraz3, Marcos Antônio Segatto Silva4, Hellen Karine Stulzer4, Diva Sonaglio4.   

Abstract

Our research group has pioneered the development of liquisolid pellets as a new drug delivery system targeting at the improvement of the dissolution rates of poorly water-soluble drugs, combining the technological and biopharmaceutical advantages of both multiparticulate and liquisolid systems. Recently, Lam and collaborators claimed the invention of "liqui-pellets" as "the emerging next-generation oral dosage form which stems from liquisolid concept in combination with pelletization technology". However, the concept of liqui-pellet is not novel. As we demonstrate in this commentary, liqui-pellets are the same type of preparation as our previously and extensively reported liquisolid pellets. Liquisolid pellets have been disclosed in a patent application and public peer-reviewed articles covering the concept, preparation and challenges associated with these systems. There are no technical differences that justify excluding our previous reports as the first reports on liquisolid pellets or liqui-pellets. This commentary highlights the similarities between liquisolid pellets and liqui-pellets, focusing on the anteriority of liquisolid pellets as disclosed by our group.

Entities:  

Keywords:  extrusion-spheronization; liqui-pellets; liquisolid pellets; pellets

Mesh:

Substances:

Year:  2020        PMID: 31953566     DOI: 10.1208/s12249-019-1590-x

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  2 in total

1.  Rapid releasing naproxen Liqui-Pellet using effervescent agent and neusilin US2.

Authors:  Matthew Lam; Kofi Asare-Addo; Ali Nokhodchi
Journal:  Iran J Basic Med Sci       Date:  2021-01       Impact factor: 2.699

2.  Liquisolid System and Liqui-Mass System Are Not the Same.

Authors:  Matthew Lam; Taravat Ghafourian; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2020-03-16       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.